Alkem Laboratories balance sheet

As of Mar 2026

Total assets: ₹20,873cr+18.0% on Mar 2025
Shareholders' equity: ₹14,349cr+15.4% on Mar 2025
Total debt: ₹1,624cr+52.8% on Mar 2025
Cash and investments: ₹985cr−18.3% on Mar 2025

₹ crore except per share

Tap a line for its trend	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Current assets
Non-current assets					FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	2,695	2,064	2,161	2,065
	138	477	148	310
	524	423	417	413
	652	365	295	204
	144	71.5	10.2	13.0
	1,132	943	335	305
	0.0	0.0	0.0	8.0
	1,216	475	120	295
	2,347	1,419	455	608
	1,819	1,738	1,515	1,303
	343	188	162	110
	8,662	6,745	5,163	5,027
	3,333	2,922	2,661	2,608
	737	902	149	317
	2,979	2,466	2,253	2,132
	248	304	455	274
	1,485	1,259	1,124	2,343
	6.6	9.0	9.1	6.8
	2,523	2,115	2,930	190
	7,978	7,056	6,920	5,263
	899	833	830	736
	12,211	10,811	10,412	8,606
	—	135	0.0	123
	20,873	17,691	15,575	13,757
Equity
	23.9	23.9	23.9	23.9
	13,796	11,961	10,288	9,021
	13,820	11,985	10,312	9,045
	529	449	402	390
	14,349	12,434	10,714	9,435
Liabilities
	492	311	40.0	70.3
	784	621	500	166
	1,277	932	540	236
	431	338	300	369
	15.1	0.0	—	—
	18.1	22.0	25.8	8.8
	1,741	1,292	866	615
	1,131	752	1,174	1,326
	2,244	1,839	1,748	1,165
	821	842	661	633
	4,196	3,433	3,583	3,124
	201	159	127	373
	66.5	61.1	55.0	23.4
	319	306	230	187
	4,783	3,959	3,995	3,707
	—	6.3	0.0	—
	6,524	5,257	4,861	4,322
	20,873	17,691	15,575	13,757
Trade payables — MSME split
	197	88.0	—	—
	2,047	1,751	—	—

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

ALKEM₹5,079.00

Alkem Laboratories Ltd.

· Pharma & Health

₹ CrorePeersMANKIND TORNTPHARM IPCALAB LUPIN FORTIS AUROPHARMA LAURUSLABS BIOCONMcap ₹60,719 Cr

View

In ₹ Crore except Per Share As of	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	2,065.4	2,161.5	2,063.9	2,695.0	2,695.0
+ Capital Work-in-Progress	310.3	148.4	476.6	137.9	137.9
+ Goodwill	413.2	416.7	423.1	523.6	523.6
+ Other Intangibles	204.3	294.6	365.3	652.4	652.4
+ Intangibles under Development	13.0	10.2	71.5	143.9	143.9
+ Non-current Investments	304.6	334.8	943.2	1,131.5	1,131.5
+ Long-term Loans	8.0	0.0	0.0	0.0	0.0
+ Other Non-current Financial Assets	295.3	120.2	475.4	1,215.7	1,215.7
Non-current Financial Assets	607.9	455.0	1,418.6	2,347.2	2,347.2
+ Deferred Tax Assets	1,302.5	1,514.8	1,738.3	1,819.4	1,819.4
+ Other Non-current Assets	110.5	162.1	188.1	343.0	343.0
Total Non-current Assets	5,027.0	5,163.3	6,745.3	8,662.5	8,662.5
Current Assets
+ Inventories	2,607.5	2,661.2	2,922.4	3,333.2	3,333.2
+ Current Investments	317.2	149.0	902.3	737.3	737.3
+ Trade Receivables	2,132.2	2,252.8	2,466.3	2,979.1	2,979.1
+ Cash & Cash Equivalents	273.8	455.1	304.1	247.9	247.9
+ Other Bank Balances	2,343.1	1,124.3	1,258.9	1,485.0	1,485.0
+ Short-term Loans	6.8	9.1	9.0	6.6	6.6
+ Other Current Financial Assets	189.8	2,930.2	2,115.5	2,522.5	2,522.5
Current Financial Assets	5,262.8	6,920.4	7,056.1	7,978.5	7,978.5
+ Other Current Assets	736.1	830.0	832.7	898.8	898.8
Total Current Assets	8,606.4	10,411.6	10,811.2	12,210.5	12,210.5
+ Assets Held for Sale	123.3	0.0	134.6	—	—
Total Assets	13,756.7	15,574.9	17,691.1	20,873.0	20,873.0
Equity
+ Equity Share Capital	23.9	23.9	23.9	23.9	23.9
+ Other Equity / Reserves	9,021.4	10,288.2	11,961.0	13,796.2	13,796.2
Equity — Owners of Parent	9,045.3	10,312.1	11,984.9	13,820.1	13,820.1
+ Minority Interest	389.7	402.3	448.8	528.8	528.8
Total Equity	9,435.0	10,714.4	12,433.6	14,348.9	14,348.9
Liabilities
+ Borrowings — Non-current	70.3	40.0	310.9	492.5	492.5
+ Other Non-current Financial Liab	166.0	500.3	621.4	784.5	784.5
Non-current Financial Liabilities	236.3	540.3	932.3	1,276.9	1,276.9
+ Provisions — Non-current	369.4	299.9	338.2	431.2	431.2
+ Deferred Tax Liabilities	—	—	0.0	15.1	15.1
+ Other Non-current Liabilities	8.8	25.8	22.0	18.1	18.1
Non-current Liabilities	614.5	866.0	1,292.5	1,741.3	1,741.3
+ Borrowings — Current	1,326.4	1,174.0	751.9	1,131.1	1,131.1
+ Trade Payables	1,165.0	1,748.1	1,839.4	2,244.2	2,244.2
+ Other Current Financial Liab	632.7	661.0	841.6	821.1	821.1
Current Financial Liabilities	3,124.1	3,583.0	3,432.8	4,196.3	4,196.3
+ Provisions — Current	372.8	126.9	159.1	200.7	200.7
+ Current Tax Liabilities	23.4	55.0	61.1	66.5	66.5
+ Other Current Liabilities	186.9	229.7	305.7	319.2	319.2
Current Liabilities	3,707.2	3,994.6	3,958.7	4,782.7	4,782.7
+ Liabilities Held for Sale	—	0.0	6.3	—	—
Total Liabilities	4,321.7	4,860.5	5,257.5	6,524.0	6,524.0
Total Equity & Liabilities	13,756.7	15,574.9	17,691.1	20,873.0	20,873.0
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	—	88.0	197.1	197.1
+ Dues to Other Creditors — Current	—	—	1,751.4	2,047.0	2,047.0

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.